• Amicus Therapeutics, Inc. (NASDAQ:FOLD) Given Average Rating of "Moderate Buy" by Analysts

    来源: Buzz FX / 15 1月 2025 02:56:16   America/New_York


    Amicus Therapeutics, Inc. (NASDAQ:FOLD) Given Average Rating of "Moderate Buy" by Analysts Written by MarketBeat January 15, 2025 Share Link copied to clipboard. Amicus Therapeutics, Inc. ( NASDAQ:FOLD - Get Free Report ) has been assigned
    Read more...
分享